Submitted by barrons9707 in business
Eli Lilly says the list price of its obesity drug, Zepbound, is roughly 20% lower than the list price of Novo Nordisk's Wegovy.
Submitted by barrons9707 in business
Eli Lilly says the list price of its obesity drug, Zepbound, is roughly 20% lower than the list price of Novo Nordisk's Wegovy.